- Home
- ADCT vs CDLX Comparison
ADCT vs CDLX Comparison
Compare ADCT & CDLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- CDLX
- Stock Information
- Founded
- ADCT 2011
- CDLX 2008
- Country
- ADCT Switzerland
- CDLX United States
- Employees
- ADCT N/A
- CDLX N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- CDLX Computer Software: Programming Data Processing
- Sector
- ADCT Health Care
- CDLX Technology
- Exchange
- ADCT Nasdaq
- CDLX Nasdaq
- Market Cap
- ADCT 224.3M
- CDLX 180.4M
- IPO Year
- ADCT 2020
- CDLX 2018
- Fundamental
- Price
- ADCT $1.72
- CDLX $3.42
- Analyst Decision
- ADCT Strong Buy
- CDLX Hold
- Analyst Count
- ADCT 5
- CDLX 6
- Target Price
- ADCT $8.00
- CDLX $5.90
- AVG Volume (30 Days)
- ADCT 709.5K
- CDLX 936.2K
- Earning Date
- ADCT 03-12-2025
- CDLX 03-13-2025
- Dividend Yield
- ADCT N/A
- CDLX N/A
- EPS Growth
- ADCT N/A
- CDLX N/A
- EPS
- ADCT N/A
- CDLX N/A
- Revenue
- ADCT $70,717,000.00
- CDLX $293,468,000.00
- Revenue This Year
- ADCT $6.81
- CDLX N/A
- Revenue Next Year
- ADCT $11.23
- CDLX $3.49
- P/E Ratio
- ADCT N/A
- CDLX N/A
- Revenue Growth
- ADCT N/A
- CDLX N/A
- 52 Week Low
- ADCT $1.68
- CDLX $2.76
- 52 Week High
- ADCT $6.04
- CDLX $20.52
- Technical
- Relative Strength Index (RSI)
- ADCT 41.61
- CDLX 48.09
- Support Level
- ADCT $1.68
- CDLX $2.76
- Resistance Level
- ADCT $2.14
- CDLX $3.92
- Average True Range (ATR)
- ADCT 0.14
- CDLX 0.26
- MACD
- ADCT 0.00
- CDLX -0.02
- Stochastic Oscillator
- ADCT 16.35
- CDLX 54.35
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.
About CDLX Cardlytics Inc.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K., and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.